Hyperactivation of the complement and coagulation systems is recognized as part of the
clinical syndrome of COVID-19. Here we review systemic complement activation and local …

Long COVID has become a world-wide, non-communicable epidemic, caused by long-
lasting multiorgan symptoms that endure for weeks or months after SARS-CoV-2 infection …

In rare instances, pediatric SARS-CoV-2 infection results in a novel immunodysregulation
syndrome termed multisystem inflammatory syndrome in children (MIS-C). We compared …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus was identified in
China in 2019 as the causative agent of COVID-19, and quickly spread throughout the …

The acute manifestations and short-term outcomes of multisystem inflammatory syndrome
(MIS-C) have been extensively described; however, our understanding of the longitudinal …

Coronavirus disease 2019 (COVID-19) represents a major public health crisis that has
caused the death of nearly six million people worldwide. Emerging data have identified a …

MIS-C is a systemic inflammation disorder with poorly characterised immunopathological
mechanisms. We compared changes in the systemic immune response in children with MIS …

Multisystem inflammatory syndrome in children (MIS-C) is a rare, life-threatening
complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

The clinical presentation of MIS-C overlaps with other infectious/non-infectious diseases
such as acute COVID-19, Kawasaki disease, acute dengue, enteric fever, and systemic …

Background Despite similar rates of infection, adults and children have markedly different
morbidity and mortality related to severe acute respiratory syndrome coronavirus-2 (SARS …